- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04119544
Mirror Therapy Rehabilitation of the Upper Limb After Stroke (NEURO-MIROIR 2) (NEUROMIROIR2)
Intensive Rehabilitation Program With Intensive Visual Numerical Simulation Device for Improving Distal Motor Performance and Upper Limb Functional Capacity in Subacute Hemiparetics After Stroke. Randomized Controlled Trial.
Hemiparesis is a common motor disorder after a stroke. The majority of patients do not recover functional use of their paretic upper limb.
The use of mirror therapy allows the activation of the mirror neurons involved to stimulate brain plasticity after brain damage.The IVS (Intensive Visual Stimulation) device allows an easy implementation of mirror therapy by filming the valid upper limb and projecting the inverted image onto a screen placed above the parietal arm thus producing the illusion of movement of the parietal arm.
The main hypothesis of this study is that the structured practice of a large number of upper limb targeted movement repetitions using an intensive visual numerical simulation device as a partial replacement for routine care (conventional occupational therapy) in the sub-acute phase of stroke will increase the active function (motor function and functional abilities) of the distal end of the upper limb compared to conventional rehabilitation.
Objectives: This randomized controlled trial will evaluate the effects of partial substitution of routine care (occupational therapy) by structured movement repetition programs by Intensive Visual Simulation using an IVS3 device, on the distal motor control of the upper hemiparesis limb, between 4 and 10 weeks after the stroke, compared to a program with conventional care alone.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Hemiparesis is a common motor disorder after a stroke. The majority of patients do not reuse their paretic upper limb.
Hypothesis: The structured practice of repeating upper limb movements by Intensive Visual Simulation will increase distal motor control, and improve the objective functional abilities of the upper limb.
Main Objective:Evaluate in a controlled protocol the effects, on the distal motor control of the upper hemiparesis limb, between 4 and 10 weeks after stroke, of 6 weeks of partial substitution of routine care (occupational therapy) by structured movement repetition programs by Intensive Visual Simulation using an IVS3 device, compared to 6 weeks of a program involving only conventional rehabilitation care, in a population of moderate to severe hemiparesis stroke patients in subacute phase.
Device Description: The IVS3 (Intensive Visual Simulation) rehabilitation device, marketed by Dessintey, allows the implementation of intensive mirror therapy by making it more immersive, ergonomic, and accessible. The IVS3 device consists of a hollow table adjustable in height, a touch screen dedicated to the therapist to set up the device and a large screen adjustable in height and sliding laterally to overlap the upper limb and thus allow the illusion that the limb visible on the screen is the paretic upper limb.
Methods: Multicentric randomised controlled Trial.
Risk/Constraint: To our knowledge, this research does not involve any risks other than those of daily life. The medical device will be used under normal conditions of use as described in the user manual. No contraindications are specified for this device. A risk of discomfort may be felt by the patient during the first few minutes of use. Possibility of feeling tired.
Research duration : 3 years Duration of patient participation : 18 weeks
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Christophe DURET, MD
- Phone Number: +33 164 718 000
- Email: direction@les-trois-soleils.fr
Study Contact Backup
- Name: Cécile FAURE
- Email: direction@les-trois-soleils.fr
Study Locations
-
-
-
Boissise-le-Roi, France, 77310
- Recruiting
- Clinique Les Trois Soleils
-
Contact:
- Christophe Duret, MD
- Email: ch.duret@les-trois-soleils.fr
-
Principal Investigator:
- Christophe Duret, MD
-
Cosne-Cours-sur-Loire, France, 58200
- Recruiting
- CRF Pasori
-
Contact:
- Nikolay Dobrev, MD
- Email: n.dobrev@pasori.fr
-
Principal Investigator:
- Nikolay Dobrev, MD
-
Villiers-sur-Orge, France, 91700
- Recruiting
- Clinalliance Villiers-sur Orge
-
Contact:
- Manuel Wiese, MD
- Email: dr.wiese@villiers.clinalliance.fr
-
Principal Investigator:
- Véronique Ediere, MD
-
Principal Investigator:
- Manuel Wiese, MD
-
Sub-Investigator:
- Elisabeth Alais, MD
-
-
Champagne-Ardenne
-
Reims, Champagne-Ardenne, France, 51092
- Not yet recruiting
- CHU Sébastopol
-
Contact:
- François BOYER, PhD
- Phone Number: +33 326 788 597
- Email: fboyer@chu-reims.fr
-
Contact:
- Véronique ROUVROY
- Phone Number: +33 326 788 597
- Email: vrouvroy@chu-reims.fr
-
Sub-Investigator:
- Gaël BELASSIAN, MD
-
Sub-Investigator:
- Sandy CARAZO MENDEZ, MD
-
Sub-Investigator:
- Amandine RAPIN, MD
-
Principal Investigator:
- François BOYER, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age ≥18 years;
- Stroke hemiparesis on unilateral focal lesion dating from 4 to 10 weeks at baseline;
- Total sub-scores wrist and hand of th Fugl-Meyer < 16
- Patient having agreed to sign an informed consent
- patient being affiliated to the French Social Security
Exclusion Criteria:
- Cognitive dysfunction or progressive intercurrent illness making effective communication or participation in the study impossible
- Phasic disorders that prevent the understanding of instructions
- Patient include in an other clinical trial
- Neurological conditions prior to stroke
- Patient who had mirror therapy or IVS rehabilitation before inclusion
- Rheumatological pathology of the hand and wrist
- Person under legal protection measure.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Conventional Rehabilitation
at least 4 sessions/week for 6 weeks, from 1 hour of conventional upper limb rehabilitation by an occupational therapist.
|
upper limb rehabilitation involving submaximal passive amplitude stretching movements, inhibition postures, active efforts assisted of varying difficulty, target approach exercises with or without elbow support and gripping tasks, adapted to the upper limb's paresis abilities.
The patient will be encouraged to gradually dispense with the assistance provided by the therapist or any technical assistance (suspension...) and thus to carry out the exercises in free active as soon as possible.
|
Experimental: Intensive Visual Simulation
at least 4 sessions/week for 6 weeks, of 1 hour of upper limb rehabilitation including 45 minutes of conventional rehabilitation (occupational therapy) and 15 minutes of work with a medical device allowing intensive visual digital simulation.
|
upper limb rehabilitation involving submaximal passive amplitude stretching movements, inhibition postures, active efforts assisted of varying difficulty, target approach exercises with or without elbow support and gripping tasks, adapted to the upper limb's paresis abilities.
The patient will be encouraged to gradually dispense with the assistance provided by the therapist or any technical assistance (suspension...) and thus to carry out the exercises in free active as soon as possible.
Conventional rehabilitation upper limb rehabilitation involving submaximal passive amplitude stretching movements, inhibition postures, active efforts assisted of varying difficulty, target approach exercises with or without elbow support and gripping tasks, adapted to the upper limb's paresis abilities. The patient will be encouraged to gradually dispense with the assistance provided by the therapist or any technical assistance (suspension...) and thus to carry out the exercises in free active as soon as possible. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of motor performance score on the Fugl-Meyer sub-score wrist/hand
Time Frame: between Day1(day of program start), Week6 (end of the program)
|
Fugl-Meyer (FM) assessment for measures of the motor impairment of the upper-limb; the sub-score wrist/hand includes items related to movements of the forearm (proximal arm), wrist, hand (distal arm) and speed/coordination during a finger-nose task.
The total sub-score range between 0 and 30.
|
between Day1(day of program start), Week6 (end of the program)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of motor performance score on the Fugl-Meyer
Time Frame: between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)
|
Fugl-Meyer (FM) assessment for measures of the motor impairment of the upper-limb; the test includes items related to movements of the shoulder, elbow, forearm (proximal arm), and wrist and hand (distal arm).
The total scores range between 0 and 66.
|
between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)
|
Change of motor capacity on Stroke Upper Limb Capacity Scale (SULCS)
Time Frame: between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)
|
The scale measures active upper limb capacity in hemiparesis based on 10 items, with each item having a possible score of 0 or 1.
Three items for arm capacity without active hand capacity, four items for arm capacity and basic hand capacity and three items for complex hand capacity.The total scores range between 0 and 10.
|
between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)
|
Change of spasticity score of the elbow flexors, wrist flexors, finger flexors measured by the Modified Ashworth Scale (MAS)
Time Frame: between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)
|
The Modified Ashworth scale (MAS) measures resistance during passive soft-tissue stretching and is used as a simple measure of spasticity. Scoring :0: No increase in muscle tone
|
between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)
|
Change in perceived stroke impact on the Stroke Impact Scale (SIS)
Time Frame: between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)
|
The Stroke Impact Scale (SIS) is a 59 item patient reported outcome measure, covering 8 domains: strength (4 items), hand function (5 items), mobility (9 items), activities of daily living (10 items), memory (7 items), communication (7 items), emotion (9 items), and handicap (8 items).
Domains are scored on a metric of 0 to 100, with higher scores indicating better self-reported health.
Four of the scales of the SIS can be combined into a composite physical domain (strength, hand function, physical and instrumental activities of daily living, and mobility), with scores also presented on a 0 to 100 metric.
|
between Day1(day of program start), Week6 (end of the program) and Week18 (12 weeks after the end of the program)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Christophe DURET, MD, Clinique Les Trois Soleils
- Principal Investigator: Yannick BLANCHETEAU, MD, Clinalliance Villiers-sur-Orge
- Principal Investigator: Nikolay DOBREV, MD, CRF Pasori
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-A00966-51
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.RecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, CryptogenicSingapore, Philippines
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Vanderbilt University Medical CenterPatient-Centered Outcomes Research Institute; University of Alabama at BirminghamEnrolling by invitationStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Engagement, Patient | Stroke HemorrhagicUnited States
-
University of MinnesotaAmerican Occupational Therapy FoundationRecruitingStroke | Stroke Sequelae | Stroke Hemorrhagic | Stroke IschemicUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
University of CincinnatiMedical University of South Carolina; University of California, Los Angeles; University...RecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke HemorrhagicUnited States
-
University of LiegeCompletedStroke, Acute | Stroke Hemorrhagic | Stroke, ComplicationBelgium
-
Turkish Stroke Research and Clinical Trials NetworkElectroCore INC; Turkish Neurological SocietyCompletedStroke | Stroke, Ischemic | Stroke, Acute | Stroke, HemorrhagicTurkey
Clinical Trials on Conventional rehabilitation
-
Ankara Physical Medicine and Rehabilitation Education...CompletedSpinal Cord Injury CervicalTurkey
-
Gaziosmanpaşa Training and Research Hospital, University...CompletedStroke | HemiplegiaTurkey
-
Centro Hospitalar de Vila Nova de Gaia/Espinho,...Not yet recruitingArthritis, Rheumatoid | Arthritis, Psoriatic | Limitation, Mobility | Hand Deformity | Hand Arthritis | Deformity, HandPortugal
-
Afyonkarahisar Health Sciences UniversityCompletedCerebral Palsy | Rehabilitation | Hand Functions | Robotic RehabilitationTurkey
-
Centre for Interdisciplinary Research in Rehabilitation...Recruiting
-
Ege UniversityCompletedOsteoarthritis, Hip | Physical Disability | Arthroplasty ComplicationsTurkey
-
Sword Health, SAUniversity of California, San FranciscoCompletedMusculoskeletal Pain | Chronic Shoulder Pain | Shoulder TendinopathyUnited States
-
Bezmialem Vakif UniversityCompletedHemiplegia | Respiratory AbnormalityTurkey
-
Vetrea Terveys OyKuopio University Hospital; City of KuopioRecruiting